Back
Snowflake, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
15
SNOW
Snowflake, Inc.
Last Price:
$222.24
Seasonality Move:
-20.37%
Sell
23
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$33.50
Seasonality Move:
-0.96%
Sell
15
Snowflake, Inc. (SNOW)
is a Sell
Is Snowflake, Inc. a Buy, Sell or Hold?
-
The current Snowflake, Inc. [SNOW] share price is $222.46. The Score for SNOW is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
SNOW is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNOW Stock Price Chart
What is Snowflake, Inc.'s stock price today?
-
The Snowflake, Inc. share price today is $222.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNOW is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $33.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.
SNOW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 41.47 | Buy |
| Relative Strength Index (14 RSI): | 40.7 | Sell |
| Chaikin Money Flow: | 2866607 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (221.04 - 253.14) | Sell |
| Bollinger Bands (100): | (209.66 - 255.38) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.24 | Buy |
| Relative Strength Index (14 RSI): | 45.54 | Sell |
| Chaikin Money Flow: | 579058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.65 - 35.95) | Sell |
| Bollinger Bands (100): | (29.19 - 34.19) | Buy |
SNOW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 218.87 | Buy |
| 20-day SMA: | 233.27 | Sell |
| 50-day SMA: | 247.5 | Sell |
| 200-day SMA: | 208.24 | Buy |
| 8-day EMA: | 116.76 | Buy |
| 20-day EMA: | 57.12 | Buy |
| 50-day EMA: | 24.89 | Buy |
| 200-day EMA: | 6.5 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.82 | Sell |
| 20-day SMA: | 34.8 | Sell |
| 50-day SMA: | 33.74 | Sell |
| 200-day SMA: | 33.57 | Sell |
| 8-day EMA: | 17.59 | Buy |
| 20-day EMA: | 8.61 | Buy |
| 50-day EMA: | 3.75 | Buy |
| 200-day EMA: | 0.98 | Buy |
Snowflake, Inc. Earnings Growth & SNOW Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.09 per share, and an increase next year of $0.51 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Snowflake, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||